Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort

Ben Schöttker1, Mariam A Adamu, Melanie N Weck

  • 1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. b.schoettker@dkfz-heidelberg.de

Atherosclerosis
|December 23, 2011
PubMed

Insights

Helicobacter pylori infection, including cagA-positive strains, does not increase cardiovascular disease or mortality risk. Interestingly, cagA-positive H. pylori infection shows an inverse association with fatal cardiovascular events.

Area of Science:

  • Cardiovascular epidemiology
  • Infectious disease research
  • Gastroenterology

Background:

  • Helicobacter pylori (H. pylori) is a primary cause of chronic atrophic gastritis (CAG).
  • The link between H. pylori infection and cardiovascular disease (CVD) risk remains debated.
  • CAG is also being investigated for its potential role in systemic diseases.

Purpose of the Study:

  • To investigate the association between H. pylori infection and CAG with cardiovascular disease and mortality.
  • To determine if H. pylori infection status, particularly with cytotoxin-associated gene A (cagA) strains, impacts risks for myocardial infarction, stroke, and overall mortality.

Main Methods:

  • A population-based German cohort of 9953 older adults (50-74 years) was studied.
  • Serological tests measured H. pylori infection and pepsinogen (PG) levels.
  • Cox regression analysis assessed hazard ratios (HR) for cardiovascular events and mortality over five years.

Main Results:

  • Over 50% of participants were infected with H. pylori; 5.7% had CAG.
  • No increased risk for myocardial infarction, stroke, or all-cause mortality was linked to H. pylori infection (cagA-negative or cagA-positive).
  • A significant inverse association was found between cagA-positive H. pylori infection and cardiovascular mortality (HR: 0.62).

Conclusions:

  • H. pylori infection and CAG are not supported as risk factors for cardiovascular disease or mortality.
  • An inverse relationship between cagA-positive H. pylori infection and fatal cardiovascular events is suggested.
  • Further research may clarify the complex interplay between H. pylori and cardiovascular health.
Abstract

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...